Coherus Oncology Reports 75% Confirmed ORR in First-Line ESCC
Confirmed ORR was 100% among PD-L1-positive patients.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.